Is Augmentin (amoxicillin-clavulanate) an appropriate treatment for a patient with bronchitis, considering the potential for bacterial infection and underlying respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin for Bronchitis

Augmentin (amoxicillin-clavulanate) should NOT be prescribed for acute uncomplicated bronchitis in otherwise healthy adults, as it provides no clinical benefit—reducing cough by only half a day while significantly increasing adverse effects. 1

Critical Distinction: Acute Bronchitis vs. Chronic Bronchitis Exacerbations

The answer depends entirely on whether you're treating acute bronchitis (a viral illness) or acute exacerbations of chronic bronchitis/COPD (which may be bacterial).

For Acute Bronchitis (Immunocompetent Adults)

Do NOT prescribe Augmentin or any antibiotic. 1, 2

  • Respiratory viruses cause 89-95% of acute bronchitis cases, making antibiotics completely ineffective regardless of which one you choose. 2
  • A randomized controlled trial specifically comparing amoxicillin-clavulanate to placebo showed no significant difference in days with cough: amoxicillin-clavulanate resulted in 11 days of cough versus 11 days with placebo. 1
  • Antibiotics only reduce cough duration by approximately 0.5 days (12 hours) while significantly increasing adverse events (RR 1.20; 95% CI 1.05-1.36). 1, 2

Common pitfalls to avoid:

  • Do NOT assume bacterial infection based on purulent or discolored sputum—this occurs in 89-95% of viral cases and does not indicate bacterial infection. 1, 2
  • Do NOT prescribe antibiotics based on cough duration alone—viral bronchitis cough typically lasts 10-14 days, sometimes up to 3 weeks. 2
  • Do NOT prescribe antibiotics to meet patient expectations—patient satisfaction depends more on physician-patient communication than whether an antibiotic is prescribed. 2

What TO do instead:

  • Inform patients that cough typically lasts 10-14 days after the visit, even without antibiotics, and may persist up to 3 weeks. 2
  • Consider antitussives (codeine or dextromethorphan) for bothersome dry cough, especially when sleep is disturbed. 1, 2
  • Consider β2-agonist bronchodilators only in select patients with accompanying wheezing. 1, 2

When to reassess:

  • If fever persists beyond 3 days—this strongly suggests bacterial superinfection or pneumonia rather than simple viral bronchitis. 1, 2
  • If cough persists beyond 3 weeks—consider other diagnoses such as asthma, COPD, pertussis, or gastroesophageal reflux. 2

For Acute Exacerbations of Chronic Bronchitis/COPD

Augmentin MAY be appropriate in specific high-risk situations. 2, 3

Indications for antibiotics (including Augmentin):

  • Patients with chronic respiratory insufficiency (dyspnea at rest and/or FEV1 <35% with hypoxemia PaO2 <60 mmHg). 2
  • Patients meeting at least 2 of 3 Anthonisen criteria: increased dyspnea, increased sputum volume, or increased sputum purulence. 2
  • High-risk patients (age >65 years with moderate-to-severe COPD, cardiac failure, insulin-dependent diabetes, or serious neurological disorders). 2

Augmentin dosing for chronic bronchitis exacerbations:

  • Standard dose: 875/125 mg twice daily for 7 days. 3
  • High-dose formulation: 2,000/125 mg (Augmentin XR) twice daily for 5 days—shown to be as effective as the 7-day standard course with high bacteriological efficacy (76.7% success rate). 3
  • Augmentin provides coverage for β-lactamase-producing H. influenzae and M. catarrhalis, which account for up to 25% and 50-70% of cases respectively. 2, 4

Alternative antibiotics to consider:

  • First-line for infrequent exacerbations: amoxicillin, first-generation cephalosporins, macrolides, or doxycycline. 2
  • Second-line for frequent exacerbations or FEV1 <35%: respiratory fluoroquinolones (levofloxacin, moxifloxacin) or second/third-generation cephalosporins. 2

Before Diagnosing Bronchitis: Rule Out Pneumonia

Always check vital signs and perform chest examination before diagnosing bronchitis. 1, 2

Pneumonia is likely (NOT bronchitis) if any of the following are present:

  • Heart rate >100 beats/min. 2
  • Respiratory rate >24 breaths/min. 2
  • Oral temperature >38°C. 2
  • Abnormal chest examination findings (rales, egophony, tactile fremitus, or focal consolidation). 1, 2

If any of these are present, obtain chest radiography and treat as pneumonia, not bronchitis. 2

Special Consideration: Asthma and COPD Mimics

Approximately one-third of patients diagnosed with "recurrent acute bronchitis" actually have undiagnosed asthma or COPD exacerbations. 2

  • Differential diagnoses such as exacerbations of chronic airways diseases (COPD, asthma, bronchiectasis) may require other therapeutic management (such as oral corticosteroids) rather than antibiotics. 1
  • If the patient has known asthma or COPD, you are NOT treating simple acute bronchitis—different management applies. 1, 2

Exception: Pertussis

For confirmed or suspected pertussis (whooping cough), prescribe a macrolide antibiotic (erythromycin or azithromycin), NOT Augmentin. 1, 2

  • Patients with pertussis should be isolated for 5 days from the start of treatment. 2
  • Early treatment within the first few weeks diminishes coughing paroxysms and prevents disease spread. 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.